• United States

U.S. Pharma Stocks Analysis

NasdaqGM:PROC
NasdaqGM:PROC
NasdaqGM:PROCPharmaceuticals

Procaps Group S.A.'s (NASDAQ:PROC) most bullish insider, CEO Ruben Minski must be pleased with the recent 12% gain

May 19, 2022
To get a sense of who is truly in control of Procaps Group S.A. ( NASDAQ:PROC ), it is important to understand the...
NasdaqGM:CGTX
NasdaqGM:CGTX
NasdaqGM:CGTXPharmaceuticals

Despite recent gains, Cognition Therapeutics, Inc. (NASDAQ:CGTX) insiders are still down US$187k after purchasing last year

May 19, 2022
Insiders who bought US$246k worth of Cognition Therapeutics, Inc. ( NASDAQ:CGTX ) stock in the last year have seen some...
NasdaqCM:AYTU
NasdaqCM:AYTU
NasdaqCM:AYTUPharmaceuticals

Earnings Release: Here's Why Analysts Cut Their Aytu BioPharma, Inc. (NASDAQ:AYTU) Price Target To US$8.00

May 19, 2022
It's been a pretty great week for Aytu BioPharma, Inc. ( NASDAQ:AYTU ) shareholders, with its shares surging 18% to...
NasdaqGS:PHAT
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

Insider Buying: The Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Co-Founder & COO Just Bought 2.6% More Shares

May 19, 2022
Investors who take an interest in Phathom Pharmaceuticals, Inc. ( NASDAQ:PHAT ) should definitely note that the...
NasdaqGM:RETA
NasdaqGM:RETA
NasdaqGM:RETAPharmaceuticals

Even after rising 14% this past week, Reata Pharmaceuticals (NASDAQ:RETA) shareholders are still down 70% over the past three years

May 18, 2022
This week we saw the Reata Pharmaceuticals, Inc. ( NASDAQ:RETA ) share price climb by 14%. But that doesn't change the...
NasdaqCM:RGC
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

Founder Yat-Gai Au Just Bought A Handful Of Shares In Regencell Bioscience Holdings Limited (NASDAQ:RGC)

May 18, 2022
Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) shareholders (or potential shareholders) will be happy to see that...
NYSE:ZTS
NYSE:ZTS
NYSE:ZTSPharmaceuticals

An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 21% Undervalued

May 17, 2022
Today we will run through one way of estimating the intrinsic value of Zoetis Inc. ( NYSE:ZTS ) by taking the forecast...
NasdaqGM:TFFP
NasdaqGM:TFFP
NasdaqGM:TFFPPharmaceuticals

We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully

May 17, 2022
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
NasdaqGM:IKNA
NasdaqGM:IKNA
NasdaqGM:IKNAPharmaceuticals

Further weakness as Ikena Oncology (NASDAQ:IKNA) drops 12% this week, taking one-year losses to 79%

May 17, 2022
It's not a secret that every investor will make bad investments, from time to time. But it would be foolish to simply...
  • 1
  • 2
  • 3
  • 4
  • 5
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.